论文部分内容阅读
Aim: Glibenclamide, originally applied to treat type 2 diabetes mellitus, is currently known to exert a new pharmacological effect.In this study we explored the possible inhibitory effect of glibenclamide on T-cell-mediated inflammatory responses.